Authors: Pellet, C Chevret, S Blum, L Gauville, C Hurault, M Blanchard, G Agbalika, F Lascoux, C Ponscarme, D Morel, P Calvo, F Lebbe, C

Citation: C. Pellet et al., Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy, J INVES DER, 117(4), 2001, pp. 858-863

Authors: Sereni, D Tubiana, R Lascoux, C Katlama, C Taulera, O Bourque, A Cohen, A Dvorchik, B Martin, RR Tournerie, C Gouyette, A Schechter, PJ

Citation: D. Sereni et al., Pharmacokinetics and tolerability of intravenous Trecovirsen (GEM (R) 91),an antisense phosphorothioate oligonucleotide, in HIV-positive subjects, J CLIN PHAR, 39(1), 1999, pp. 47-54

Authors: Hoen, B Dumon, B Harzic, M Venet, A Dubeaux, B Lascoux, C Bourezane, Y Ragnaud, JM Bicart-See, A Raffi, F Beauvais, L Fleury, H Sereni, D

Citation: B. Hoen et al., Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: Results of the ANRS 053 trial, J INFEC DIS, 180(4), 1999, pp. 1342-1346